Result of AGM

AI SummaryClose X

BioPharma Credit PLC announced that all resolutions presented at its 2026 Annual General Meeting were passed by poll, with strong support for most proposals. The annual report and financial statements received 100% approval, and the dividend policy was also unanimously approved. While the election of Nigel Reynolds as a Director saw 98.80% in favour, the re-election of Harry Hyman as a Director received 84.08% of the votes. The company also secured substantial approval for auditor re-appointment and market share purchases, with approximately 41% of total voting rights cast across the resolutions.

Disclaimer*

UK 100